Provectus Biopharmaceuticals, Inc.../ US74373P1084 /
| 5/22/2024 5:15:13 PM | Chg. 0.0000 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.1900USD | 0.00% | 33,363 Turnover: 6,302.9501 |
-Bid Size: - | -Ask Size: - | 0.1900 | 0.1881 |
GlobeNewswire
5/21
Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Fu...
GlobeNewswire
5/14
Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial...
GlobeNewswire
5/2
Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of...
GlobeNewswire
4/18
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Pro...
GlobeNewswire
4/16
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder...
GlobeNewswire
4/11
Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC a...
GlobeNewswire
3/27
Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miam...
GlobeNewswire
3/12
Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Benga...
GlobeNewswire
3/7
Provectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC a...
GlobeNewswire
2/29
Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstrac...
GlobeNewswire
12/18/2023
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodiu...
GlobeNewswire
11/15/2023
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutane...
GlobeNewswire
11/13/2023
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uvea...
GlobeNewswire
11/6/2023
Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at So...
GlobeNewswire
3/24/2022
Provectus Biopharmaceuticals Announces Synthesis of New Halogenated Xanthene Small Molecule
GlobeNewswire
2/16/2022
Provectus Biopharmaceuticals Announces Acceptance of PV-10® Metastatic Uveal Melanoma Abstract for O...
GlobeNewswire
2/8/2022
Provectus Biopharmaceuticals Announces Acceptance of PV-10® Systemic Administration Abstract at Amer...
GlobeNewswire
1/27/2022
Provectus Biopharmaceuticals Provides Update on Research into PV-10® Immunotherapy as an Immune Adju...
GlobeNewswire
1/10/2022
Provectus Biopharmaceuticals Announces Publication of Pharmaceutical-Grade Rose Bengal’s Activity Ag...
GlobeNewswire
11/1/2021
Provectus Biopharmaceuticals Announces Presentation of Meta-Analysis Results of Single-Agent PV-10® ...
GlobeNewswire
10/28/2021
Provectus Biopharmaceuticals Announces Presentation of Updated Data from Combination Therapy Trial o...
